Internal Oncology Program 2

About Leash Biosciences

Leash Biosciences is an AI-native biotech leveraging a unique data-generation engine to solve the core data gap in machine learning for drug discovery. The company's platform rapidly measures billions of protein-compound interactions, using this data to iteratively train models that design and test novel molecules, with a current capacity of screening 96 protein targets per week. While developing its own internal oncology programs, Leash also partners with biopharma companies, positioning itself as both a therapeutics developer and a platform technology provider. The company is led by a team with deep expertise in digital chemistry, laboratory automation, and data science, supported by advisors from top-tier institutions.

Therapeutic Areas

Other Oncology Drugs